Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
REACT-AF
NCT05836987Phase 3Recruiting
- Sponsor
- Johns Hopkins University
- Start
- Jul 2023
- Primary completion
- Jul 2029
- Countries
- 1
01
Overview
A Phase 3 trial of rivaroxaban in Atrial fibrillation (AFib), sponsored by Johns Hopkins University. Started Jul 2023; status: recruiting.
02
Drugs
rivaroxaban
03
Conditions
Atrial fibrillation (AFib)
Beyond the preview
Go deeper on NCT05836987.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05836987.